Evidence map›Paper›PMID 41768766›Full record

ArticleACS central science2026

Which Reaction Conditions Work on Drug-Like Molecules? Lessons from 66,000 High-Throughput Experiments.

Jesse Ahlbrecht, Marius D R Lutz, Vera Jost, Michael Färber, Stefan Bräse, Georg Wuitschik

Abstract read
In one paragraph

Article in ACS central science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jesse AhlbrechtInstitute of Biological and Chemical Systems, Karlsruhe Institute of Technology (KIT), 76131 Karlsruhe, Germany.
Marius D R LutzRoche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.
Vera JostRoche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.
Michael FärberAI Center ScaDS.AI Dresden/Leipzig, TUD Dresden University of Technology, 01069 Dresden, Germany.
Stefan BräseInstitute of Biological and Chemical Systems, Karlsruhe Institute of Technology (KIT), 76131 Karlsruhe, Germany.
Georg WuitschikRoche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland.ORCID https://orcid.org/0000-0001-6682-1213

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-throughput experimentation (HTE) accelerates chemical discovery by shortening the lead times for molecule synthesis. The choice of initial reaction conditions directly influences the outcome and length of any reaction optimization. But human involvement in plate design and data analysis remains a significant cost factor and is accompanied by biases. Therefore, making the most out of past reaction outcomes is crucial. While advances in machine learning allow us to generate promising reaction conditions, this approach is often not suitable because not enough relevant reaction data are available or it is of insufficient quality. Herein we introduce a robust statistical method using

Identifiers

PMID41768766
PMCPMC12947288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.